Family-Based Behavioral Therapy for Childhood Anxiety and OCD

DA
ES
Overseen ByEric Storch, Ph.D.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two types of family-based treatments delivered online for children with anxiety or obsessive-compulsive disorder (OCD). It compares these treatments to a relaxation and mentorship program that includes breathing exercises with a therapist. The goal is to determine which method is most effective and how they benefit children. Families with children aged 7 to 13 who exhibit noticeable anxiety or OCD symptoms may be suitable participants, especially if the child can engage in therapy and a parent can attend the sessions. As an unphased trial, this study provides families with an opportunity to explore innovative treatment options that could significantly enhance their child's well-being.

Do I need to stop my current medications to join the trial?

You don't need to stop your current medications, but they must be stable for a certain period before joining the trial. If you're on an antidepressant, it should be stable for 12 weeks, and for other medications like antipsychotics or ADHD meds, it should be stable for 6 weeks. Any changes to your medication should have been made at least 4 weeks before joining.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that family-based, online cognitive behavioral therapy (iCBT) for anxiety and OCD in young people can significantly reduce anxiety symptoms. Past participants found this type of therapy easy to handle.

For the Relaxation and Mentorship Training (RMT), family-based therapy that includes relaxation exercises is generally safe for children with anxiety. However, it may not reduce symptoms as effectively as more intensive CBT methods.

Overall, both treatment approaches are considered safe for children. They use therapy and relaxation techniques, which are common and generally accepted for treating childhood anxiety and OCD.12345

Why are researchers excited about this trial?

Researchers are excited about these treatment approaches for childhood anxiety and OCD because they offer family-centered, accessible solutions that differ from traditional therapies like individual CBT or medication. The Parent Training Bibliotherapy (SPACE) method empowers parents with structured guidance and literature, encouraging them to independently manage their child's anxiety with professional support. The Family-Based Internet-Based CBT (iCBT) introduces a novel, digital approach where parents lead their children through exposure tasks, an essential CBT component, with therapist support via video and email. Lastly, the Relaxation and Mentorship arm emphasizes stress-reduction techniques, like deep breathing and muscle relaxation, in a family-inclusive setting, which can foster a supportive environment for the child. These approaches aim to involve the family more deeply in the therapeutic process, potentially enhancing efficacy and accessibility.

What evidence suggests that this trial's treatments could be effective for childhood anxiety and OCD?

Research has shown that family-based cognitive behavioral therapy (CBT), one of the treatments in this trial, effectively reduces anxiety and OCD symptoms in children. Studies indicate that online family-based CBT, particularly with therapist support, lowers anxiety disorders in children. Additionally, family-centered approaches tailored to a child's needs have improved OCD symptoms.

In this trial, another group of participants will receive relaxation and mentorship training (RMT). Studies suggest that RMT is less effective than exposure-focused CBT, a therapy that gradually introduces children to their fears. While RMT can help reduce stress through activities like breathing exercises, it generally does not reduce anxiety as much as other CBT methods.23567

Are You a Good Fit for This Trial?

This trial is for children aged 7-13 in Texas with significant anxiety or OCD, as indicated by specific test scores. They must have the ability to engage in CBT and live with a participating parent at least half the time. Children on stable medication may qualify, but those starting new treatments recently or changing dosages are excluded.

Inclusion Criteria

The participating parent/guardian lives with their child at least 50% of the time per self-report
The child is appropriate for anxiety-focused treatment as diagnosed using the Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
One parent/guardian is able and willing to participate in assessment and treatment
See 5 more

Exclusion Criteria

My child currently has severe thoughts of harming themselves or others, needing medical help.
My child is currently being treated for anxiety.
My mental health medications have been stable for the last 4 weeks.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive one of three interventions: Relaxation and Mentorship Training, SPACE, or iCBT over 12-14 weeks

12-14 weeks
4-6 video calls (30-45 minutes each), additional email support

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Family Based
  • Relaxation and Mentorship
Trial Overview The study compares family-based and internet-delivered cognitive behavioral therapy (CBT) against Relaxation and Mentorship Training (RMT). It aims to determine which method is more effective for treating anxiety and OCD in youth through telehealth services.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Parent Training Bibliotherapy (SPACE)Experimental Treatment1 Intervention
Group II: Family-Based Internet-Based CBT Group (iCBT)Experimental Treatment1 Intervention
Group III: Active ComparatorActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor College of Medicine

Lead Sponsor

Trials
1,044
Recruited
6,031,000+

Published Research Related to This Trial

A study involving 20 families with young children diagnosed with OCD found that both Cognitive-Behavioral Family-Based Treatment (CBFT) and Parent Training (PT) led to clinical improvements in obsessive-compulsive symptoms, indicating that parent-only interventions can be effective.
CBFT was more effective than PT in reducing externalizing problems, suggesting that while parent-only interventions are feasible, having the child present during treatment may provide additional benefits for certain symptoms.
A preliminary study of cognitive-behavioral family-based treatment versus parent training for young children with obsessive-compulsive disorder.Rosa-Alcázar, AI., Iniesta-Sepúlveda, M., Storch, EA., et al.[2022]
Family-based interventions are effective in treating pediatric obsessive-compulsive disorder (OCD) by improving how family members manage symptoms and interact with each other.
The article emphasizes the importance of understanding family dynamics and provides practical guidance on implementing family-based cognitive-behavioral therapy, supported by empirical evidence and case examples.
Family-Based Treatment of Pediatric Obsessive-Compulsive Disorder: Clinical Considerations and Application.Anderson, LM., Freeman, JB., Franklin, ME., et al.[2018]
This study is a randomized clinical trial comparing family-based cognitive behavioral therapy (FCBT) to family-based psychoeducation and relaxation training (FPRT) in children and adolescents aged 8-17 with obsessive-compulsive disorder (OCD), aiming to include at least 128 participants to ensure robust results.
The trial is designed to minimize bias and enhance the reliability of findings by using blinding for assessors and randomizing therapists to deliver both interventions, allowing for a clearer understanding of the specific benefits and harms of FCBT compared to FPRT.
Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial).Pagsberg, AK., Uhre, C., Uhre, V., et al.[2022]

Citations

Family-Based Treatment of Early Childhood OCDA comprehensive, family based CBT program was superior to a relaxation program with similar format in reducing OCD symptoms and functional impairment in young ...
Treating child anxiety using family-based internet delivered ...Online family-based cognitive behaviour therapy reduces child anxiety disorders. •. Therapist support during online child anxiety programs may be important for ...
Comparative Effectiveness of Internet-based Versus Parent ...This research is being done to understand the comparative effectiveness of two different types of cognitive-behavioral therapy (CBT) for treating anxiety or OCD ...
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/18356758/
Early childhood OCD: preliminary findings from a family-based ...Results indicate that children with early-onset OCD benefit from a treatment approach tailored to their developmental needs and family context.
Family-based cognitive behavioral therapy versus ...Few randomized clinical trials (RCTs) have compared cognitive behavioral therapy (CBT) versus active control interventions for pediatric ...
Controlled Comparison of Family Cognitive Behavioral ...FCBT is effective for reducing OCD severity and impairment. Importantly, treatment also reduced parent-reported involvement in symptoms with reduced ...
Comparing outcomes for children with different anxiety ...The purpose of this study was to compare treatment outcomes following a group family-based cognitive behavioural therapy for children with different anxiety ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security